Skip to main content
Clinical Trials/NCT06897501
NCT06897501RecruitingNot Applicable

Incidence of Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophagectomy: a Multicenter Randomized Controlled Trial

Samsung Medical Center1 site in 1 country202 target enrollmentStarted: April 14, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
202
Locations
1
Primary Endpoint
Postoperative vocal cord palsy

Study Overview

Brief Summary

The goal of this clinical trial is to investigate whether the use of bronchial blocker could reduce the incidence of postoperative vocal cord palsy than the use of double-lumen endobronchial tube in robot-assisted esophagectomy.

Detailed Description

Esophagectomy is a challenging surgery that usually requires one lung ventilation, and double-lumen endobronchial tubes and bronchial blockers are commonly used for one lung ventilation.

Successful resection of recurrent laryngeal nerve lymph nodes during esophagectomy is important to survival and prevention of cancer recurrence, but there is a risk of postoperative vocal cord palsy due to the recurrent laryngeal nerve injury during the resection.

Compared to a double-lumen endobronchial tube, the use of a bronchial blocker is expected to reduce the incidence of recurrent laryngeal nerve injury; however, few clinical studies compare the two devices in terms of the incidence of postoperative vocal cord palsy in robot-assisted esophagectomy.

Therefore, the researchers aimed to investigate whether the use of bronchial blocker could reduce the incidence of postoperative vocal cord palsy than the use of double-lumen endobronchial tube in robot-assisted esophagectomy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults aged 19 or older
  • •American Society of Anesthesiologists physical status I - III
  • •Elective robot-assisted esophagectomy
  • •Any clinical stage of esophageal cancer
  • •Patients who need recurrent laryngeal nerve lymph nodes resection

Exclusion Criteria

  • •Patients who diagnosed vocal cord palsy or damage before surgery
  • •Patients who need specific airway device due to airway problem
  • •History of thoracic surgery
  • •Emergency surgery
  • •Combined surgery with other department
  • •Pregnant or nursing women

Arms & Interventions

double-lumen endobronchial tube group

Active Comparator

Intervention: double-lumen endobronchial tube (Device)

bronchial blocker group

Experimental

Intervention: bronchial blocker (Device)

Outcomes

Primary Outcomes

Postoperative vocal cord palsy

Time Frame: On postoperative day 7 after robot-assisted esophagectomy

On postoperative day 7, ENT doctor will performed the laryngoscopy exam to check the presence of vocal cord palsy.

Secondary Outcomes

  • Number of resected recurrent laryngeal nerve lymph nodes(At the end of surgery)
  • Surgical difficulty reported by surgeon(At the end of surgery)
  • Quality of one lung ventilation(during one lung ventilation)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hyun Joo Ahn

Professor, Anesthesiologist

Samsung Medical Center

Study Sites (1)

Loading locations...

Similar Trials